Xabier G. L. D. O.
- Country
- Spain
- Department
- Hematología
Research Overview
- Phase III Randomized Trial of Bortezomib, Melphalan, Prednisone, Lenalidomide, Dexamethasone, Carfilzomib, and Daratumumab in Elderly Patients with Newly Diagnosed Multiple Myeloma
- Phase III Trial Comparing Extended Lenalidomide-Bortezomib-Dexamethasone with Early Rescue vs. Isatuximab-Lenalidomide-Bortezomib-Dexamethasone vs. Isatuximab-Lenalidomide-Iberdomide-Dexamethasone in Newly Diagnosed Multiple Myeloma Candidates for Autologous Stem Cell Transplantation
- A Phase 3 Randomized Study Comparing Talquetamab in Combination with Pomalidomide (Tal-P), Talquetamab in Combination with Teclistamab (Tal-Tec), and Investigator’s Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pomalidomide, Bortezomib, and Dexamethasone (PVd) in Participants with Relapsed or Refractory Myeloma who Have Received 1 to 4 Prior Lines of Therapy Including an Anti-CD38 Antibody and Lenalidomide
Data & Insights
Has run more than one trial at 43 of 115 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating multiple myeloma, with particular expertise in managing both newly diagnosed and relapsed/refractory cases.
- Advanced Multiple Myeloma Treatment
- Age-Specific Therapeutic Approaches
- Novel Combination Therapies
Their clinical focus includes developing treatment strategies for elderly patients aged 65-80 years with newly diagnosed multiple myeloma.
Therapeutic Innovation
The investigator explores innovative treatment combinations including immunomodulatory agents and proteasome inhibitors for multiple myeloma management.
- Targeted Therapy Applications
- Immunotherapy Approaches
- Maintenance Treatment Strategies
Their work encompasses both standard treatment protocols and experimental therapeutic combinations.
Treatment Optimization
The investigator focuses on optimizing therapeutic outcomes through personalized treatment approaches for different patient populations.
- Response Assessment Methods
- Treatment Sequencing Strategies
- Patient-Specific Protocols
Their expertise includes evaluating treatment efficacy in various patient subgroups and developing tailored therapeutic strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.